Evofem Biosciences, Inc.

Industry

  • Biotechnology
  • Pharmaceuticals
    • Specialty Pharmaceuticals
    • Vaccines

Other Names/Subsidiaries

  • Cosmederm Bioscience
  • Lithera
  • Neothetics.
See more in Biomedtracker

Latest on Evofem Biosciences, Inc.

Pink Sheet

How To Leverage US FDA’s ‘Consistent With Labeling’ Guidance In DTC Ads

 
• By Sue Sutter

Sponsors should review longstanding US Food and Drug Administration concepts on consumer-friendly language and claims limitations, and Office of Prescription Drug Promotion research priorities and enf

Scrip

Deal Watch: Revance To Go Private In Crown Laboratories Buyout

 
• By Joseph Haas and Vibha Ravi

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Crown Will Offer $924m To Merge With Re

Scrip

Deal Watch: Six Small Biopharma Mergers Reflect Recent Trend

 
• By Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. In this edition of Deal Watch, we highl

Pink Sheet

Efficacy Overstatements In Evofem’s Phexxi Brochure, Otsuka’s Rexulti TV Ad Draw Untitled Letters

 
• By Brenda Sandburg

The US Food and Drug Administration’s Office of Prescription Drug Promotion issued untitled letters to Evofem Biosciences, Inc. and Otsuka Pharmaceutical Development and Commercialization Inc. objec